146 related articles for article (PubMed ID: 37144735)
1. Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma.
Van Laar R; Latif B; King S; Love C; Taubenheim N; Kalansooriya E; Wang W; Saad M; Winship I; Azzi A; Lilleyman A; Landgren T
Br J Dermatol; 2023 Aug; 189(3):292-301. PubMed ID: 37144735
[TBL] [Abstract][Full Text] [Related]
2. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
[No Abstract] [Full Text] [Related]
3. Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma.
Van Laar R; Lincoln M; Fereday S
PLoS One; 2019; 14(2):e0211504. PubMed ID: 30721246
[TBL] [Abstract][Full Text] [Related]
4. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
6. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
Monroe MM; Pattisapu P; Myers JN; Kupferman ME
Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR
Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971
[TBL] [Abstract][Full Text] [Related]
9. A novel microRNA signature for the detection of melanoma by liquid biopsy.
Sabato C; Noviello TMR; Covre A; Coral S; Caruso FP; Besharat ZM; Splendiani E; Masuelli L; Battistelli C; Vacca A; Catanzaro G; Po A; Anichini A; Maio M; Ceccarelli M; Di Giacomo AM; Ferretti E
J Transl Med; 2022 Oct; 20(1):469. PubMed ID: 36243798
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy status is strongly predictive of survival in cutaneous melanoma: Extended follow-up of Oxford patients from 1998 to 2014.
Thomson DR; Rughani MG; Kuo R; Cassell OCS
J Plast Reconstr Aesthet Surg; 2017 Oct; 70(10):1397-1403. PubMed ID: 28625757
[TBL] [Abstract][Full Text] [Related]
11. Analysis of disease free survival in cutaneous melanoma patients subject to sentinel lymph node biopsy.
Łobaziewicz W; Szloch J; Wajda J; Legkiy O; Marczyk E; Wysocki W
Pol Przegl Chir; 2020 Mar; 92(3):15-21. PubMed ID: 32759393
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of sentinel lymph node biopsy for patients with cutaneous melanoma: A retrospective study of surveillance, epidemiology, and end-result population-based data.
Chen J; Xu Y; Zhou Y; Wang Y; Zhu H; Shi Y
Oncotarget; 2016 Jul; 7(29):45671-45677. PubMed ID: 27344178
[TBL] [Abstract][Full Text] [Related]
13. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
14. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
[TBL] [Abstract][Full Text] [Related]
15. A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response.
van Laar RK; Lincoln MT; van Laar BJ
Melanoma Res; 2019 Feb; 29(1):19-22. PubMed ID: 30320629
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy for melanoma: indications and rationale.
Phan GQ; Messina JL; Sondak VK; Zager JS
Cancer Control; 2009 Jul; 16(3):234-9. PubMed ID: 19556963
[TBL] [Abstract][Full Text] [Related]
17. Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients.
Hao H; Xiao D; Pan J; Qu J; Egger M; Waigel S; Sanders MA; Zacharias W; Rai SN; McMasters KM
Ann Surg Oncol; 2017 Jan; 24(1):108-116. PubMed ID: 27663566
[TBL] [Abstract][Full Text] [Related]
18. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
19. Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary.
Johansson I; Tempel D; Dwarkasing JT; Rentroia-Pacheco B; Mattsson J; Ny L; Olofsson Bagge R
Eur J Surg Oncol; 2022 Feb; 48(2):320-325. PubMed ID: 34794843
[TBL] [Abstract][Full Text] [Related]
20. A critical reappraisal of false negative sentinel lymph node biopsy in melanoma.
Manca G; Romanini A; Rubello D; Mazzarri S; Boni G; Chiacchio S; Tredici M; Duce V; Tardelli E; Volterrani D; Mariani G
Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):105-13. PubMed ID: 24835287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
